D721HZZ
Stereotactic Radiosurgery Thymus to None with None, Stereotactic Particulate Radiosurgery Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | 7 Lymphatic and Hematologic System |
| Operation | 2 Stereotactic Radiosurgery |
| Body Part | 1 Thymus |
| Approach | H Stereotactic Particulate Radiosurgery |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Stereotactic radiosurgery applied to the lymphatic and hematologic system delivers a small number of highly focused, high-dose radiation beams to a spleen, lymph node mass, or other lymphatic structure, most often as treatment for localized lymphoma, splenic involvement in a blood disorder, or an isolated recurrence after other therapy has failed. Unlike conventional radiation given in many small daily doses over weeks, this approach uses precise imaging guidance to concentrate the dose in one to five sessions while sparing nearby organs such as the kidney, stomach, or bowel.
Physicians choose this route when a lesion is well-defined on imaging and located where a tighter margin of healthy tissue can be spared, or when a patient cannot tolerate a longer conventional course. It is also used for oligometastatic or residual disease that persists after chemotherapy, giving a second chance at local control without a full course of systemic treatment.
Because the equipment involved (Gamma Knife-type or linear accelerator systems with stereotactic guidance) is specialized, this treatment is typically planned by a radiation oncology team and delivered at centers with the appropriate technology.
Anatomy & Axis Detail
Thymus
The thymus, an anterior mediastinal lymphoid organ central to T-cell maturation, largely involutes with age but can give rise to thymomas or thymic carcinomas. Stereotactic radiosurgery targets a discrete thymic mass with a highly conformal, image-guided dose delivered in one or a few fractions, useful when a lesion is unresectable or when treating residual or recurrent disease after thymectomy. Its position anterior to the great vessels and adjacent to the pericardium and lungs demands tight dose conformality to protect the heart and lung parenchyma from the steep gradients this technique produces. Careful immobilization and respiratory motion management matter given the cardiac and pulmonary motion near this structure.
Modality Qualifier: Stereotactic Particulate Radiosurgery
Stereotactic Particulate Radiosurgery refers to single- or limited-fraction radiosurgical treatment delivered with charged particle beams, such as protons, using stereotactic targeting to achieve sharp dose falloff around a small lesion. Its particle physics gives it a different depth-dose profile than the photon-based stereotactic techniques, making it useful when sparing tissue just beyond the target is a priority, unlike Stereotactic Other Photon Radiosurgery or Gamma Beam approaches.
Coding & Documentation
The coder needs documentation confirming stereotactic technique specifically, such as a treatment planning note referencing a stereotactic frame, frameless immobilization system, or image-guided targeting, plus the number of fractions delivered and the qualifier describing dose delivery. A simple mention of 'high-dose radiation to the spleen' is not enough; the record must support that beam delivery met the stereotactic definition rather than standard external beam therapy.
A frequent assignment error is defaulting to the Beam Radiation root operation because the treatment sounds like ordinary external beam therapy, when the physician's planning documentation actually describes stereotactic delivery. Coders should also confirm the body system value reflects the specific lymphatic structure treated (spleen versus a nodal chain) rather than defaulting to a generic lymphatic code, since the physical body part treated determines the correct table row.